BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10436894)

  • 1. A general methodology for three-dimensional analysis of variation in target volume delineation.
    Remeijer P; Rasch C; Lebesque JV; van Herk M
    Med Phys; 1999 Jun; 26(6):931-40. PubMed ID: 10436894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy.
    Deurloo KE; Steenbakkers RJ; Zijp LJ; de Bois JA; Nowak PJ; Rasch CR; van Herk M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):228-38. PubMed ID: 15629616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of the prostate in CT and MRI: a multi-observer study.
    Rasch C; Barillot I; Remeijer P; Touw A; van Herk M; Lebesque JV
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):57-66. PubMed ID: 9989514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study.
    Lütgendorf-Caucig C; Fotina I; Stock M; Pötter R; Goldner G; Georg D
    Radiother Oncol; 2011 Feb; 98(2):154-61. PubMed ID: 21176984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers.
    van der Wielen GJ; Mutanga TF; Incrocci L; Kirkels WJ; Vasquez Osorio EM; Hoogeman MS; Heijmen BJ; de Boer HC
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1604-1611.e3. PubMed ID: 19028284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter- and intra-observer variability in contouring of the prostate gland on planning computed tomography and cone beam computed tomography.
    Choi HJ; Kim YS; Lee SH; Lee YS; Park G; Jung JH; Cho BC; Park SH; Ahn H; Kim CS; Yi SY; Ahn SD
    Acta Oncol; 2011 May; 50(4):539-46. PubMed ID: 21391773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
    Barkati M; Simard D; Taussky D; Delouya G
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of high dose volumetric CT to reduce inter-observer delineation variability and PTV margins for prostate cancer radiotherapy.
    Alasti H; Cho YB; Catton C; Berlin A; Chung P; Bayley A; Vandermeer A; Kong V; Jaffray D
    Radiother Oncol; 2017 Oct; 125(1):118-123. PubMed ID: 28859933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR.
    Smith WL; Lewis C; Bauman G; Rodrigues G; D'Souza D; Ash R; Ho D; Venkatesan V; Downey D; Fenster A
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1238-47. PubMed ID: 17336224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study.
    Court LE; Dong L; Taylor N; Ballo M; Kitamura K; Lee AK; O'Daniel J; White RA; Cheung R; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):412-8. PubMed ID: 15145157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses.
    Rosewall T; Kong V; Vesprini D; Catton C; Chung P; Ménard C; Bayley A
    Radiother Oncol; 2009 Mar; 90(3):325-30. PubMed ID: 19121547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study.
    Gerlich AS; van der Velden JM; Kotte ANTJ; Tseng CL; Fanetti G; Eppinga WSC; Kasperts N; Intven MPW; Pameijer FA; Philippens MEP; Verkooijen HM; Seravalli E
    Radiother Oncol; 2018 Mar; 126(3):534-540. PubMed ID: 28919003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer.
    Villeirs GM; Van Vaerenbergh K; Vakaet L; Bral S; Claus F; De Neve WJ; Verstraete KL; De Meerleer GO
    Strahlenther Onkol; 2005 Jul; 181(7):424-30. PubMed ID: 15995835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer.
    Debois M; Oyen R; Maes F; Verswijvel G; Gatti G; Bosmans H; Feron M; Bellon E; Kutcher G; Van Poppel H; Vanuytsel L
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):857-65. PubMed ID: 10571190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tri-modality image fusion method for target delineation of brain tumors in radiotherapy.
    Guo L; Shen S; Harris E; Wang Z; Jiang W; Guo Y; Feng Y
    PLoS One; 2014; 9(11):e112187. PubMed ID: 25375123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy.
    Dubois DF; Prestidge BR; Hotchkiss LA; Prete JJ; Bice WS
    Radiology; 1998 Jun; 207(3):785-9. PubMed ID: 9609905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning.
    Perna L; Cozzarini C; Maggiulli E; Fellin G; Rancati T; Valdagni R; Vavassori V; Villa S; Fiorino C
    Radiat Oncol; 2011 Sep; 6():123. PubMed ID: 21943002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy.
    Yeung AR; Vargas CE; Falchook A; Louis D; Olivier K; Keole S; Yeung D; Mendenhall NP; Li Z
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1426-33. PubMed ID: 18762391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.